📰 Edge Pharma News
Edge Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Edge Pharma. Real-time updates on events, politics, business and more.
July 12, 2023
Analyzing the patent and trademark challenges faced by 503A compounding pharmacies.
April 29, 2023
Transtympanic Delivery System Market – Global Trends & Forecasts to 2020-2029
April 14, 2023
NORTH ADAMS, Mass. — The Berkshire Bank Foundation has awarded MCLA $20,000 to fund the Berkshire Bank STEM Academy. The program accepts up to 15 incoming first-year...
March 21, 2023
In our first appellate oral argument we found ourselves in front of a very hot Ninth Circuit panel (that means lots of questions). We danced our hardest to affirm the district court’s...
December 28, 2022
Among the pantheon of best journalism movies is All the President's Men, the riveting backstory of how the Washington Post broke open the Watergate scandal and ultimately ended Richard Nixon's presidency. The film follows reporters Bob Woodward and Carl Bernstein, played by Robert Redford and Dustin Hoffman, as they harangue reluctant sources and conduct late-night parking garage rendezvous. It's a superhero flick for nerds.
August 26, 2022
The US Court of Appeals for the First Circuit affirmed-in-part and vacated-in-part a district court ruling dismissing claims under the Lanham Act and Massachusetts consumer protection...
August 16, 2022
The First Circuit on Friday partially revived portions of Azurity Pharmaceuticals' suit against Edge Pharma over its competing hydrochloride vancomycin drug, agreeing with a Massachusetts federal court that some of its claims don't hold up, but not for the same reason.
June 22, 2022
A Vermont pharmaceutical company with a history of defying safety regulations closed last month amid mounting pressure from federal inspectors who accused it of selling...
June 15, 2022
The United States alleged that inspections revealed record-keeping violations, labelling inadequacies, improper airflow, disrepair and mold.
June 14, 2022
The U.S. Justice Department says a Vermont compounding pharmacy has agreed to stop producing adulterated and misbranded drugs